Role of CD38 in anti-tumor immunity of small cell lung cancer is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U24CA213274-02
Coordinating center for the NCI small cell lung cancer research consortium
National Institutes of Health
Grant: 5R35CA263816-02
Novel therapeutic development for small cell lung cancer
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA258784-05
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer
National Institutes of Health
Grant: 5K08CA248723-03
Assessment of Tim-4+ Pleural Macrophages as Negative Regulators of Anti-Tumor T Cell Immunity in Lung Cancer
National Institutes of Health
Grant: 5R01CA197936-02
Determinants of acquired resistance in small cell lung cancer
NCI NIH HHS
Grant: R01 CA197936
NCI NIH HHS
Grant: R01 CA258784
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: K08 CA248723
NCI NIH HHS
Grant: U24 CA213274
NCI NIH HHS
Grant: R35 CA263816
FWCI
1.05
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals